National Advisory Council Agenda

141st Meeting of the National Advisory Council on Drug Abuse

Virtual Meeting – May 10, 2022

Closed Session

This meeting is closed to the public in accordance with the provisions set forth in section 552b{c}(4) and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2). 

Time Presentation
11:00 a.m. Call to Order (15 minutes later)
Nora Volkow, M.D.
Director, NIDA


Review of Policy and Procedures
Susan Weiss, Ph.D.
Executive Secretary
National Advisory Council on Drug Abuse
Director, Division of Extramural Research, NIDA
11:15 a.m.

Council Review of Grant Applications
Nora Volkow, M.D., Director, NIDA

Office of Translational Initiatives and Program Innovationa (OTIPI)
Elena Koustova, Ph.D., M.B.A., Director

Division of Therapeutics and Medical Consequences (DTMC)
Iván Montoya, M.D., M.P.H., Acting Director

Division of Neuroscience and Behavior (DNB)
Rita Valentino, Ph.D., Director

Office of Research Training, Diversity, and Disparities (ORTDD)
Albert Avilla, Ph.D., Deputy Director

Division of Epidemiology, Services, and Prevention Research (DESPR)
Carlos Blanco, M.D., Ph.D., Director

Brief Break

12:15 p.m. Report to Council from the Board of Scientific Counselors (BSC)
Amy Newman, Ph.D., Director, NIDA IRP
Regina Carelli, Ph.D., BSC Chair
12:45 p.m. Break

Videocast:

Members of the public who may wish to express views regarding any items discussed during this meeting may do so by writing Gillian Acca, within ten days of the meeting.  Any written statements by members of the public will receive careful consideration.

Join the Videocast

Open Session

Time Presentation
1:15 p.m. Welcome and Opening Remarks
Nora Volkow, M.D., Director, NIDA
1:30 p.m. Director's Report
Nora Volkow, M.D., Director, NIDA
2:20 p.m. Discussion
Council Members
2:45 p.m. Implementation of the NIH Data Management and Sharing Policy
Mike Lauer, M.D., Deputy Director for Extramural Research, NIH
3:15 p.m. MERIT Award Discussion
Susan Weiss, Ph.D., Director, Division of Extramural Research, NIDA  
3:30 p.m. Break
3:40 p.m. Concept Clearances​
  • Division of Therapeutics and Medical Consequences (DTMC)
    • Behavioral and Integrative Treatment Development Program – Will M. Aklin, Ph.D., Health Scientist Administrator
    • HEAL: Therapeutics Development for Opioid Use Disorder in Patients with Comorbid Commonly Occurring Mental Disorders – Tanya Ramey, M.D., Ph.D., Medical Officer
    • HEAL: Rapidly Assessing the Public Health Impact of Emerging Opioid Threats – Aidan Hampson, Ph.D., Health Scientist Administrator
  • Division of Neuroscience and Behavior (DNB)
    • HRP: Novel Tools and Pipelines for High-Resolution Spatial Characterization of HIV Infection, Persistence and Pathology in CNS Tissues in Context of Substance Use – Olivier Berton, Ph.D., Acting Branch Chief, Integrative Neuroscience Branch
    • HRP: Mechanisms and Targets at the Intersection of HIV and Addictive Drugs – Sam Ananthan, Ph.D., Branch Chief, Chemistry and Pharmacology
    • Development and Validation of Virtual Assessments to Study Children and Caregivers in Their Natural Environment – Janani Prabhakar, Ph.D., Health Scientist Administrator
  • Division of Epidemiology, Services, and Prevention Research (DESPR)
    • HRP: Ending the HIV Epidemic:  Focus on Justice Populations with SUD – Tisha Wiley, Ph.D., Branch Chief, Services Research Branch
    • HEAL: Workforce Interventions to Improve Addiction Care Quality and Patient Outcomes – Tisha Wiley, Ph.D., Branch Chief, Services Research Branch
    • HRP: Ending the HIV Epidemic:  Focus on Justice Populations with SUD – Tisha Wiley, Ph.D., Branch Chief, Services Research Branch
    • HEAL: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy – Shelley Su, Ph.D., Health Scientist Administrator
    • HEAL: Research to Develop Evidence Based Opioid Misuse Prevention Interventions in Community Health Centers – Sarah Steverman, Ph.D., Health Scientist Administrator
    • HEAL: Career Development Awards in Addiction Implementation Science – Lori Ducharme, Ph.D., Health Scientist Administrator
    • HEAL: Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On – Sarah Duffy, Ph.D., Associate Director for Economics Research
    • HEAL: Opioid Use Disorder Care Pathways for Individuals with Histories of Exposure to Violence – Carrie Mulford, Ph.D., Deputy Branch Chief, Services Research Branch
    • Opioid Misuse Prevention Effectiveness Research among Youth and Families involved in the Child Welfare System – Barbara Oudekerk, Ph.D., Social Behavioral Scientist Administrator
  • Office of Translational Initiatives and Program Innovations (OTIPI)
    • CODE (Cause of Death Elucidated) in Drug Overdose: Rapid and Portable Cause of Death Detection Technologies to Improve Drug Overdose-Related Mortality Counts – Tam Nguyen, Ph.D., Health Scientist Administrator
4:00 p.m. Using AoU to Research Drug Abuse Solutions
Joshua Denny, M.D., M.S., Chief Executive Officer, All of Us, NIH 
4:30 p.m. Public Comments
4:45 p.m. Adjourn